FDA.reportPublic FDA data

Campral 333 MG (equivalent to acamprosate 300 MG) Delayed Release Oral Tablet

RxCUI
835728
RxNorm name
Campral 333 MG (equivalent to acamprosate 300 MG) Delayed Release Oral Tablet
Display name
Campral 333 MG (equivalent to acamprosate 300 MG) Delayed Release Oral Tablet
Full name
Campral 333 MG (equivalent to acamprosate 300 MG) Delayed Release Oral Tablet
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:29

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
fe6f754f-62b4-4c86-805d-221332409516Campral 333 MG Delayed Release Oral Tablet [PSN] · acamprosate calcium 333 MG Delayed Release Oral Tablet [Campral] [SBD] · Campral 333 MG (equivalent to acamprosate 300 MG) Delayed Release Oral Tablet [SY]33These highlights do not include all the information needed to use CAMPRAL safely and effectively. See full prescribing information for CAMPRAL. CAMPRAL® (acamprosate calcium) Delayed-Release Tablets Initial U.S. Approval: 200420160806